Newsroom

MD Anderson statement on BCBS TX ending Medicare Advantage and Medicaid plans

October 29, 2024

Blue Cross Blue Shield notified The University of Texas MD Anderson Cancer Center it will end its Letter of Agreement for Medicare Advantage and Texas Managed Medicaid services, effective Nov. 1, 2024. This does not impact UT System or Texas A&M System retirees on these plans, patients on BCBS commercial or managed care insurance plans, or Medicare patients with a BCBS Medicare Supplemental Plan.

While MD Anderson welcomes...

Allison Institute scientific symposium features spatial biology breakthroughs, $5 million gift to support further efforts

BY Clayton Boldt

October 14, 2024

The James P. Allison Institute at The University of Texas MD Anderson Cancer Center hosted its second annual scientific...

MD Anderson and Summit Therapeutics announce strategic collaboration to accelerate development of ivonescimab

BY Clayton Boldt

July 25, 2024

The University of Texas MD Anderson Cancer Center and Summit Therapeutics, Inc. today announced a strategic five-year collaboration agreement...

MD Anderson and Rice launch Cancer Bioengineering Collaborative

June 27, 2024

The University of Texas MD Anderson Cancer Center and Rice University today announced the creation of the Cancer Bioengineering Collaborative to develop innovative technologies and bioengineering approaches to improve cancer research, diagnosis and treatment.

Led by Rice’s Gang Bao, Ph.D., and MD Anderson’s Jeffrey Molldrem, M.D., the initiative aims to foster collaboration between the two institutions on fundamental and translational...